MedPath

Lithium cation

Generic Name
Lithium cation
Drug Type
Small Molecule
Chemical Formula
Li
CAS Number
7439-93-2
Unique Ingredient Identifier
8H8Z5UER66
Background

Lithium was used during the 19th century to treat gout. Lithium salts such as lithium carbonate (Li2CO3), lithium citrate, and lithium orotate are mood stabilizers. They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they counteract both mania and depression. Lithium can also be used to augment other antidepressant drugs. It is also sometimes prescribed as a preventive treatment for migraine disease and cluster headaches. The active principle in these salts is the lithium ion Li+, which having a smaller diameter, can easily displace K+ and Na+ and even Ca+2, in spite of its greater charge, occupying their sites in several critical neuronal enzymes and neurotransmitter receptors.

Indication

Lithium, in its salt forms, is used as a mood stabilizer and for the treatment of depression and mania. It is most frequently prescribed in the treatment of bipolar disorder.

Associated Conditions
Bipolar Disorder (BD), Depression, Depression, Bipolar, Acute Manic episode

A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study

Phase 4
Terminated
Conditions
Acute Bipolar Mania
Interventions
First Posted Date
2010-12-07
Last Posted Date
2014-05-08
Lead Sponsor
AstraZeneca
Target Recruit Count
131
Registration Number
NCT01254721
Locations
🇰🇷

Research Site, Seoul, Korea, Republic of

Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation

Phase 4
Completed
Conditions
Major Depressive Disorder
Suicidal Ideation
Interventions
First Posted Date
2010-06-02
Last Posted Date
2016-03-03
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
54
Registration Number
NCT01134731
Locations
🇺🇸

UAB, Birmingham, Alabama, United States

Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome

Not Applicable
Completed
Conditions
Osteoporosis Pseudoglioma
Interventions
First Posted Date
2010-04-21
Last Posted Date
2019-11-04
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
26
Registration Number
NCT01108068
Locations
🇺🇸

University of Maryland Amish Research Clinic, Lancaster, Pennsylvania, United States

Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder

Phase 4
Withdrawn
Conditions
Bipolar Disorder
First Posted Date
2010-02-24
Last Posted Date
2010-02-24
Lead Sponsor
Lawson, William B., M.D., PhD, DFAPA
Target Recruit Count
50
Registration Number
NCT01075126
Locations
🇺🇸

Howard University Hospital, Washington, District of Columbia, United States

Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord

Phase 1
Completed
Conditions
Spinal Cord Injuries
Interventions
Biological: Umbilical Cord Blood Mononuclear Cell
First Posted Date
2010-01-12
Last Posted Date
2014-01-28
Lead Sponsor
China Spinal Cord Injury Network
Target Recruit Count
8
Registration Number
NCT01046786
Locations
🇭🇰

Prince of Wales Hospital, Shatin, Hong Kong

🇭🇰

Queen Mary Hospital, Hong Kong, Hong Kong

Adult Bipolar Mania

Phase 4
Completed
Conditions
Acute Mania
Interventions
First Posted Date
2009-07-02
Last Posted Date
2012-04-19
Lead Sponsor
AstraZeneca
Target Recruit Count
356
Registration Number
NCT00931723
Locations
🇺🇦

Research Site, Vinnitsia, Ukraine

Lithium and Standard Therapy in Resistant Depression

Phase 4
Conditions
Depression
Interventions
Drug: usual care
First Posted Date
2009-06-25
Last Posted Date
2009-09-17
Lead Sponsor
Universita di Verona
Target Recruit Count
230
Registration Number
NCT00927550
Locations
🇮🇹

University of Verona, Verona, Italy

Effect of Lithium Carbonate in Patients With Amyotrophic Lateral Sclerosis

Phase 2
Completed
Conditions
Amyotrophic Lateral Sclerosis
Interventions
First Posted Date
2009-06-22
Last Posted Date
2012-10-31
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
23
Registration Number
NCT00925847
Locations
🇫🇷

Pitié-Salpêtrière Hospital, Paris, France

A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects

Phase 1
Withdrawn
Conditions
Generalized Anxiety Disease
Interventions
First Posted Date
2009-01-12
Last Posted Date
2015-03-05
Lead Sponsor
Pfizer
Registration Number
NCT00820794

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

Phase 1
Completed
Conditions
Progressive Supranuclear Palsy
Corticobasal Degeneration
Interventions
First Posted Date
2008-06-23
Last Posted Date
2024-05-17
Lead Sponsor
Westat
Target Recruit Count
17
Registration Number
NCT00703677
Locations
🇺🇸

Beth Israel Medical Center, New York, New York, United States

🇺🇸

UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

🇬🇧

Newcastle University, Newcastle upon Tyne, United Kingdom

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath